2006
DOI: 10.1124/pr.58.3.1
|View full text |Cite
|
Sign up to set email alerts
|

Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

20
594
1
30

Year Published

2008
2008
2016
2016

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 654 publications
(656 citation statements)
references
References 467 publications
20
594
1
30
Order By: Relevance
“…Serum levels of SAA rise with obesity, diabetes and the metabolic syndrome 10,11. Some studies point to a positive correlation between SAA and angiographically proven coronary artery disease, and serum concentration of SAA is reported to be a powerful predictor of cardiovascular events 12,13. It has been shown that patients with a high SAA concentration have more active atherosclerotic disease,14 but the relationship between serum SAA levels and transient myocardial ischaemia during exercise is not known.…”
Section: Discussionmentioning
confidence: 99%
“…Serum levels of SAA rise with obesity, diabetes and the metabolic syndrome 10,11. Some studies point to a positive correlation between SAA and angiographically proven coronary artery disease, and serum concentration of SAA is reported to be a powerful predictor of cardiovascular events 12,13. It has been shown that patients with a high SAA concentration have more active atherosclerotic disease,14 but the relationship between serum SAA levels and transient myocardial ischaemia during exercise is not known.…”
Section: Discussionmentioning
confidence: 99%
“…In these situations, the lipid and protein composition of HDLs can be changed via oxidative processes. As a result, the protective effect of HDLs against CHD was lost and HDLs became proatherogenic, which are known as dysfunctional HDLs (16,17,18). Ansell et al (19) showed that HDLs from subjects with CHD were proinflammatory despite very high HDL-C levels, indicating that HDLs from CHD subjects are dysfunctional.…”
Section: European Journal Of Endocrinologymentioning
confidence: 99%
“…One possible mechanism for dysfunctional HDLs is the alteration in the protein composition of HDLs in the setting of systemic inflammation and T2D. In this situation, inflammatory cytokines such as plasma interleukin-6 levels are elevated and the liver consequently produces serum amyloid A, which replaces apoA-I and paraoxonase 1 in HDL particles (16). In addition, myeloperoxidase specifically binds to apoA-I and produces reactive oxidative species.…”
Section: European Journal Of Endocrinologymentioning
confidence: 99%
“…Thus, cell cholesterol efflux to HDL, a key early step in reverse cholesterol transport mediated by ATP-binding cassette transporter A1, is reportedly impaired upon HDL oxidation. [14][15][16][17][18][19] This impairment has been ascribed to specific protein modifications such as oxidation of two-to-three Met in the major HDL protein, apolipoprotein A-I (apoA-I), that occurs at initial stages of HDL oxidation, 20-22 along with tyrosylation and protein cross-linking via the modified Tyr or Lys. 13,16,17,23 However, several studies report that oxidation enhances rather than impairs HDL functions in stimulating lipid efflux from cells 22,24-26 and protecting against atherosclerosis.…”
Section: Introductionmentioning
confidence: 99%